ABSTRACT
Particulate matter (PM) associated with pharmaceutical systems is in large part unwanted contamination in sterile products for which there are compendial guideline methods and according limits. Other products are certainly impacted by unwanted particles and appearance failures, which may be studied in a similar manner.
